Management of acute cardiovascular events in patients with COVID-19
© 2020 Liao et al. Published by IMR Press..
The pandemic of coronavirus disease 2019 (COVID-19) caused by the newly discovered virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had been noticed to have high morbidity and mortality. Apart from pneumonia, COVID-19 can also cause damage to the cardiovascular system, and co-occurring with cardiovascular injury leads to a poorer prognosis. Besides, amid the pandemic of COVID-19, the management of critical cardiovascular events needs to further account for the highly infectious coronavirus, prompt and optimal treatments, clinician's safety, and healthcare provider's capacity. This review article aims to provide more comprehensive and appropriate guidance for the management of critical cardiovascular disease, including ST-segment elevation myocardial infarction (STEMI), non-STEMI acute coronary syndrome, cardiogenic shock, acute heart failure, cardiopulmonary resuscitation, and advanced care planning, during the COVID-19 epidemic.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Reviews in cardiovascular medicine - 21(2020), 4 vom: 30. Dez., Seite 577-581 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liao, Chia-Te [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Advanced care planning |
|---|
| Anmerkungen: |
Date Completed 13.01.2021 Date Revised 13.01.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.31083/j.rcm.2020.04.140 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM319520218 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM319520218 | ||
| 003 | DE-627 | ||
| 005 | 20231225171626.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.31083/j.rcm.2020.04.140 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1065.xml |
| 035 | |a (DE-627)NLM319520218 | ||
| 035 | |a (NLM)33388002 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liao, Chia-Te |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of acute cardiovascular events in patients with COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.01.2021 | ||
| 500 | |a Date Revised 13.01.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Liao et al. Published by IMR Press. | ||
| 520 | |a The pandemic of coronavirus disease 2019 (COVID-19) caused by the newly discovered virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had been noticed to have high morbidity and mortality. Apart from pneumonia, COVID-19 can also cause damage to the cardiovascular system, and co-occurring with cardiovascular injury leads to a poorer prognosis. Besides, amid the pandemic of COVID-19, the management of critical cardiovascular events needs to further account for the highly infectious coronavirus, prompt and optimal treatments, clinician's safety, and healthcare provider's capacity. This review article aims to provide more comprehensive and appropriate guidance for the management of critical cardiovascular disease, including ST-segment elevation myocardial infarction (STEMI), non-STEMI acute coronary syndrome, cardiogenic shock, acute heart failure, cardiopulmonary resuscitation, and advanced care planning, during the COVID-19 epidemic | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a advanced care planning | |
| 650 | 4 | |a critical cardiovascular diseases | |
| 650 | 4 | |a resuscitation | |
| 700 | 1 | |a Chang, Wei-Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Wen-Liang |e verfasserin |4 aut | |
| 700 | 1 | |a Toh, Han Siong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Reviews in cardiovascular medicine |d 2000 |g 21(2020), 4 vom: 30. Dez., Seite 577-581 |w (DE-627)NLM122256573 |x 1530-6550 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2020 |g number:4 |g day:30 |g month:12 |g pages:577-581 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.31083/j.rcm.2020.04.140 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2020 |e 4 |b 30 |c 12 |h 577-581 | ||